Range Low Price High Price Comment
30 days $21.43 $22.84 Tuesday, 30th Apr 2024 LABP stock ended at $22.30. This is 0.80% less than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 1.26% from a day low at $22.18 to a day high of $22.46.
90 days $4.60 $22.84
52 weeks $0.260 $22.84

Historical Landos Biopharma, Inc. prices

Date Open High Low Close Volume
Apr 30, 2024 $22.46 $22.46 $22.18 $22.30 1 671
Apr 29, 2024 $22.36 $22.49 $22.20 $22.48 3 662
Apr 26, 2024 $22.35 $22.55 $22.31 $22.31 14 860
Apr 25, 2024 $22.84 $22.84 $22.21 $22.49 3 838
Apr 24, 2024 $22.19 $22.49 $22.07 $22.18 8 993
Apr 23, 2024 $21.96 $22.15 $21.92 $22.15 9 225
Apr 22, 2024 $21.84 $22.10 $21.61 $21.96 13 081
Apr 19, 2024 $21.70 $21.82 $21.60 $21.82 14 675
Apr 18, 2024 $21.55 $21.75 $21.55 $21.75 20 699
Apr 17, 2024 $21.46 $21.70 $21.46 $21.67 15 277
Apr 16, 2024 $21.50 $21.56 $21.43 $21.52 19 227
Apr 15, 2024 $21.51 $21.57 $21.43 $21.57 18 625
Apr 12, 2024 $21.58 $21.58 $21.50 $21.54 3 044
Apr 11, 2024 $21.53 $21.60 $21.51 $21.51 35 386
Apr 10, 2024 $21.47 $21.60 $21.46 $21.53 30 951
Apr 09, 2024 $21.51 $21.59 $21.50 $21.50 18 889
Apr 08, 2024 $21.75 $21.75 $21.47 $21.50 34 412
Apr 05, 2024 $21.46 $21.64 $21.46 $21.61 27 939
Apr 04, 2024 $21.45 $21.74 $21.45 $21.50 18 693
Apr 03, 2024 $21.46 $21.67 $21.45 $21.49 25 022
Apr 02, 2024 $21.60 $21.60 $21.45 $21.52 38 692
Apr 01, 2024 $21.45 $21.76 $21.43 $21.60 30 571
Mar 28, 2024 $21.41 $21.82 $21.35 $21.48 47 128
Mar 27, 2024 $21.40 $21.64 $21.35 $21.36 44 561
Mar 26, 2024 $21.65 $21.80 $21.36 $21.56 65 864
Click to get the best stock tips daily for free!

About Landos Biopharma, Inc.

Landos Biopharma. Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and eosinophilic esophagitis; NX-13, a gut-restricted ora... LABP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT